Publicaciones en las que colabora con Gemma Quincoces Fernández (16)

2023

  1. Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

    Pharmaceutics, Vol. 15, Núm. 3

2022

  1. A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits

    Scientific Reports, Vol. 12, Núm. 1

  2. Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate

    Pharmaceutics, Vol. 14, Núm. 1

  3. Preclinical safety of negatively charged microspheres (NCMs): Optimization of radiolabeling for in vivo and ex vivo biodistribution studies after topical administration on full-thickness wounds in a rat model

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 177, pp. 61-67

2021

  1. In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles

    Journal of Drug Delivery Science and Technology, Vol. 64

2020

  1. Incidental diagnosis of neuroendocrine tumour with 68Ga-PSMA PET/CT: Report of clinical case

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 2, pp. 102-103

  2. Preparation, radiolabeling with 99mTc and 67Ga and biodistribution studies of albumin nanoparticles covered with polymers

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 4, pp. 225-232

2019

  1. Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies

    International Journal of Pharmaceutics, Vol. 569

2017

  1. Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: Is PET imaging of pancreatic beta cell mass feasible?

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 447-455

2015

  1. Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [18F]-tetrafluoroborate

    EJNMMI Research, Vol. 5, Núm. 1, pp. 1-9

2011

  1. Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles

    Molecular Imaging and Biology, Vol. 13, Núm. 6, pp. 1215-1223

2009

  1. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539

  2. PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector

    Gene Therapy, Vol. 16, Núm. 1, pp. 136-141

2008

  1. Utilización de la11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 2, pp. 103-111

2007

  1. 13N-ammonia PET as a measurement of hindlimb perfusion in a mouse model of peripheral artery occlusive disease

    Journal of Nuclear Medicine, Vol. 48, Núm. 7, pp. 1216-1223

2006

  1. Simple automated system for simultaneous production of 11C-labeled tracers by solid supported methylation

    Applied Radiation and Isotopes, Vol. 64, Núm. 7, pp. 808-811